Christopher Primiano
General Counsel
Karyopharm Therapeutics Inc. (KPTI)Board Member
Aura Biosciences, Inc. (AURA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-01-01–present
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Karyopharm Therapeutics Inc. (KPTI) | J.D., M.B.A. Executive Vice President, Chief Business Officer, General Counsel and Secretary | $418,200 | $1,623,347 |
| 2018 | Karyopharm Therapeutics Inc. (KPTI) | J.D., M.B.A. Executive Vice President, Chief Business Officer, General Counsel and Secretary | $404,000 | $1,522,593 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.